FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 142 filers reported holding FLEXION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $680,000 | -24.6% | 75,935 | -2.9% | 0.10% | -35.0% |
| Q4 2020 | $902,000 | 0.0% | 78,170 | -9.8% | 0.16% | -22.7% |
| Q3 2020 | $902,000 | +16.8% | 86,630 | +47.6% | 0.20% | +8.0% |
| Q2 2020 | $772,000 | +293.9% | 58,710 | +135.8% | 0.19% | +172.5% |
| Q1 2020 | $196,000 | -56.4% | 24,895 | +3.5% | 0.07% | +68.3% |
| Q3 2018 | $450,000 | -16.2% | 24,050 | +15.7% | 0.04% | -16.3% |
| Q2 2018 | $537,000 | +13.5% | 20,790 | -1.5% | 0.05% | +11.4% |
| Q1 2018 | $473,000 | +39.5% | 21,100 | +55.8% | 0.04% | +37.5% |
| Q4 2017 | $339,000 | -29.2% | 13,540 | -31.6% | 0.03% | -30.4% |
| Q3 2017 | $479,000 | +22.8% | 19,790 | +2.5% | 0.05% | +17.9% |
| Q2 2017 | $390,000 | +39.8% | 19,310 | +86.0% | 0.04% | +39.3% |
| Q1 2017 | $279,000 | – | 10,380 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |